ImaRx Therapeutics files to raise $25.9M in IPO.

GOING public (Securities); IMARX Therapeutics Inc.; PHARMACEUTICAL industry; NASDAQ Stock Market; STOCK prices; CAPITAL market; UNITED States. Securities & Exchange Commission

The article reports that the biopharmaceutical company ImaRx Therapeutics Inc. has decided to go public and wanted to raise over $25.9 million in an initial public offering (IPO) of three million shares. In the U.S. Securities and Exchange Commission filing dated May 4, 2007, ImaRx said it is applying to have its shares to be listed on the Nasdaq Capital Market under the ticker symbol IMRX. The IPO price is said to be between $6.50 and $7.50 per share.